Literature DB >> 17726497

The Auckland City Hospital Device Point Prevalence Survey 2005: utilisation and infectious complications of intravascular and urinary devices.

Stephen Ritchie1, Deborah Jowitt, Sally Roberts.   

Abstract

BACKGROUND: In November 2005 a point prevalence survey of all inpatients at Auckland City Hospital was conducted to define the utilisation of intravascular and urinary devices; to measure the prevalence of infectious complications from these devices; and to provide quality assurance information about the use of these devices.
METHODS: All 830 inpatients admitted on a single day under paediatric; adult medical; adult surgical, and women's health were visited by a member of the survey team and data regarding devices in situ was collected.
RESULTS: Intravenous (IV) devices were present in 376/830 patients (45%; 95%CI 42-49), and 25/830 (3%; CI 2-4) had either confirmed infection or showed signs of infection. 33/830 patients (4%; CI 3-6) had intravascular devices in situ that were not required. Urinary devices were present in 93/830 patients (11%; CI 9-13), and 13/91 (14%; CI 8-23) had bacteriuria. A large proportion of urinary devices (19/91, 21%; CI 13-31) were found to have been inserted for inappropriate reasons.
CONCLUSION: This study provides information on the current utilisation of devices in our hospital that can be extrapolated to other public hospitals in New Zealand. Healthcare workers require ongoing education to ensure prompt removal of devices that are not required for patient care.

Entities:  

Mesh:

Year:  2007        PMID: 17726497

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  5 in total

1.  European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe.

Authors:  Peter Zarb; Herman Goossens
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

2.  Risk Factors for Vascular Catheter Infections-Findings of a Point-Prevalence Study in 78 Hospitals.

Authors:  Marzia Bonsignore; Sascha Tafelski; Karin Schwegmann; Andreas Meier-Hellmann; Oliver Witzke; Irit Nachtigall
Journal:  Dtsch Arztebl Int       Date:  2021-07-26       Impact factor: 5.594

3.  Estimating the National Population of Hospitalized Chronic Baclofen Users: A Cross-Sectional Analysis of a Commercial Claims Database.

Authors:  Natalie Schmitz; Margaret Artz; Karen Walsh; Sandeep Gaudana; James Cloyd; John Schrogie; Robert Kriel
Journal:  Drugs Real World Outcomes       Date:  2022-03-31

4.  Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review.

Authors:  S J McBride; A Upton; S A Roberts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-15       Impact factor: 3.267

5.  Preventing peripheral intravenous catheter failure by reducing mechanical irritation.

Authors:  Toshiaki Takahashi; Ryoko Murayama; Mari Abe-Doi; Maki Miyahara-Kaneko; Chiho Kanno; Miwa Nakamura; Mariko Mizuno; Chieko Komiyama; Hiromi Sanada
Journal:  Sci Rep       Date:  2020-01-31       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.